Prediction - PharmAust has an incredible amount of depth in the organization.
This has always been a goal of the board - to have a global pharmaceutical come on board.
Looking back at a previous announcement " on the Appointment of prestigious Veterinary Clinical Advisory Board PharmAust was delighted to announce the appointment of three global opinion leaders to its Veterinary Advisory Board. The Board is chaired by Dr Angela Frimberger, who is leading PharmAust’s dog clinical trials, along with Dr Barbara Kitchell, a world leading Veterinary Oncologist based in the US and Dr Christian Schirvel, who was previously the Global Head of Business Development and Licensing at Elanco. Together this team is advising PharmAust on its clinical and commercial development plans for monepantel. " dated Q2 FY 2018
As always
Best
MM
Add to My Watchlist
What is My Watchlist?
